Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 32 results.
User Information
Export Records
  1. 1.   Friend Spleen Focus-Forming Virus Activates the Tyrosine Kinase sf-Stk and the Transcription Factor PU.1 to Cause a Multi-Stage Erythroleukemia in Mice
  2. Cmarik, J.; Ruscetti, S.
  3. Viruses-Basel. 2010, Oct; 2(10): 2235-2257.
  1. 2.   The birth of a cell type
  2. Trinchieri, G.
  3. Journal of Immunology. 2007, Jan; 178(1): 3-4.
  1. 3.   Retroviral transduction of IL-7R alpha into IL-7R alpha(-/-) bone marrow progenitors: correction of lymphoid deficiency and induction of neutrophilia
  2. Jiang, Q.; Li, W. Q.; Aiello, F. B.; Klarmann, K.; Keller, J. R.; Durum, S. K.
  3. Gene Therapy. 2005, DEC; 12(24): 1761-1768.
  1. 4.   Inhibitory effects of tumor necrosis factor on hematopoiesis seen in vitro are translated to increased numbers of both committed and multipotent progenitors in TNF-deficient mice
  2. Drutskaya, M. S.; Ortiz, M.; Liepinsh, D. J.; Kuprash, D. V.; Nedospasov, S. A.; Keller, J. R.
  3. Experimental Hematology. 2005, NOV; 33(11): 1348-1356.
  1. 5.   Friend spleen focus-forming virus transforms rodent fibroblasts in cooperation with a short form of the receptor tyrosine kinase Stk
  2. Nishigaki, K.; Hanson, C.; Jelacic, T.; Thompson, D.; Ruscetti, S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, OCT 25; 102(43): 15488-15493.
  1. 6.   Activation of the Jun N-terminal kinase pathway by friend spleen focus-forming virus and its role in the growth and survival of friend virus-induced erythroleukemia cells
  2. Nishigaki, K.; Hanson, C.; Thompson, D.; Yugawa, T.; Ruscetti, S.
  3. Journal of Virology. 2005, OCT; 79(20): 12752-12762.
  1. 7.   Provision of granulocyte-macrophage colony-stimulating factor converts an autoimmune response to a self-antigen into an antitumor response
  2. Ji, Q. Y.; Gondek, D.; Hurwitz, A. A.
  3. Journal of Immunology. 2005, AUG 1; 175(3): 1456-1463.
  1. 8.   In vivo hydrodynamic delivery of cDNA encoding IL-2: Rapid, sustained redistribution, activation of mouse NK cells, and therapeutic potential in the absence of NKT cells
  2. Ortaldo, J. R.; Winkler-Pickett, R. T.; Bere, E. W.; Watanabe, M.; Murphy, W. J.; Wiltrout, R. H.
  3. Journal of Immunology. 2005, JUL 15; 175(2): 693-699.
  1. 9.   Ex vivo expanded murine bone marrow cells with a multiple cytokine cocktail retain long-term hematopoietic reconstitution potentials
  2. Yang, Q. E.; Fong, S. E.; Li, K. G.; Gonda, M. A.; Tobin, G. J.
  3. Medical Science Monitor. 2005, JUN; 11(6): BR154-BR161.
  1. 10.   Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits
  2. Petraitiene, R.; Petraitis, V.; Kelaher, A. M.; Sarafandi, A. A.; Mickiene, D.; Groll, A. H.; Sein, T.; Bacher, J.; Walsh, T. J.
  3. Antimicrobial Agents and Chemotherapy. 2005, MAY; 49(5): 2084-2092.
  1. 11.   Cooperative effect of Gag proteins p12 and capsid during early events of murine leukemia virus replication
  2. Lee, S. K.; Nagashima, K.; Hu, W. S.
  3. Journal of Virology. 2005 79(7): 4159-4169.
  1. 12.   Nitric oxide, a mediator of inflammation, suppresses tumorigenesis
  2. Hussain, S. P.; Trivers, G. E.; Hofseth, L. J.; He, P. J.; Shaikh, I.; Mechanic, L. E.; Doja, S.; Jiang, W. D.; Subleski, J.; Shorts, L.; Haines, D.; Laubach, V. E.; Wiltrout, R. H.; Djurickovic, D.; Harris, C. C.
  3. Cancer Research. 2004, OCT 1; 64(19): 6849-6853.
  1. 13.   C/EBP alpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo
  2. Heath, V.; Suh, H. C.; Holman, M.; Renn, K.; Gooya, J. M.; Parkin, S.; Klarmann, K. D.; Ortiz, M.; Johnson, P.; Keller, J.
  3. Blood. 2004, SEP 15; 104(6): 1639-1647.
  1. 14.   Aging of innate immunity: functional comparisons of NK/LAK cells obtained from bulk cultures of young and aged mouse spleen cells in high concentrations of interleukin-2
  2. Albright, J. W.; Bream, J. H.; Bere, E. W.; Young, H. A.; Winkler-Pickett, R.; Ortaldo, J. R.
  3. Experimental Gerontology. 2004 39(1): 73-82.
  1. 15.   Cochlin, a secreted von Willebrand factor type a domain-containing factor, is regulated by leukemia inhibitory factor in the uterus at the time of embryo implantation
  2. Rodriguez, C. I.; Cheng, J. G.; Liu, L.; Stewart, C. L.
  3. Endocrinology. 2004 145(3): 1410-1418.
  1. 16.   Ex vivo and in vivo biological effects of a truncated form of the receptor tyrosine kinase Stk when activated by interaction with the friend spleen focus-forming virus envelope glycoprotein or by point mutation
  2. Rulli, K.; Yugawa, T.; Hanson, C.; Thompson, D.; Ruscetti, S.; Nishigaki, K.
  3. Journal of Virology. 2004 78(9): 4573-4581.
  1. 17.   SMUCKLER/TIM4 is a distinct member of TIM family expressed by stromal cells of secondary lymphoid tissues and associated with lymphotoxin signaling
  2. Shakhov, A. N.; Rybtsov, S.; Tumanov, A. V.; Shulenin, S.; Dean, M.; Kuprash, D. V.; Nedospasov, S. A.
  3. European Journal of Immunology. 2004 34(2): 494-503.
  1. 18.   Genetic control of myreloproliferation in BXH-2 mice
  2. Turcotte, K.; Gauthier, S.; Mitsos, L. M.; Shustik, C.; Copeland, N. G.; Jenkins, N. A.; Fournet, J. C.; Jolicoeur, P.; Gros, P.
  3. Blood. 2004 103(6): 2343-2350.
  1. 19.   Effects of organ-specific loss of insulin-like growth factor-I production on murine hematopoiesis
  2. Welniak, L. A.; Karas, M.; Yakar, S.; Anver, M. R.; Murphy, W. F.; LeRoith, D.
  3. Biology of Blood and Marrow Transplantation. 2004 10(1): 32-39.
  1. 20.   Functional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: Effects of chimeric nucleocapsid on the retroviral replication cycle
  2. Fu, W.; Hu, W. S.
  3. Journal of Virology. 2003 77(1): 754-761.
  1. 21.   Frequent dual initiation of reverse transcription in murine leukemia virus-based vectors containing two primer-binding sites
  2. Voronin, Y. A.; Pathak, V. K.
  3. Virology. 2003 312(2): 281-294.
  1. 22.   Retroviral mutation rates and reverse transcriptase fidelity
  2. Svarovskaia, E. S.; Cheslock, S. R.; Zhang, W. H.; Hu, W. S.; Pathak, V. K.
  3. Frontiers in Bioscience. 2003 8: D117-D134.
  1. 23.   Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues
  2. Tumanov, A. V.; Kuprash, D. V.; Lagarkova, M. A.; Grivennikov, S. I.; Abe, K.; Shakhov, A. N.; Drutskaya, L. N.; Stewart, C. L.; Chervonsky, A. V.; Nedospasov, S. A.
  3. Immunity. 2002 17(3): 239-250.
  1. 24.   cis-acting elements important for retroviral RNA packaging specificity
  2. Beasley, B. E.; Hu, W. S.
  3. Journal of Virology. 2002 76(10): 4950-4960.
  1. 25.   Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development
  2. Steingrimsson, E.; Tessarollo, L.; Pathak, B.; Hou, L.; Arnheiter, H.; Copeland, N. G.; Jenkins, N. A.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2002 99(7): 4477-4482.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel